Molecular Cytogenetics Market

Molecular Cytogenetics Market to reach at an estimated value of USD
1.9 billion in 2019.
The molecular cytogenetics market has grown from $469.2 million in 2012 to an estimated $1.9 billion
in 2019 due to the success of techniques such as fluorescence in situ hybridization (FISH) and array
comparative genomic hybridization (aCGH). The research report scrutinizes the global market and
provides a quantitative and qualitative analysis on the various segments.
According to a recent study published by Transparency Market Research (TMR), the global molecular
diagnostics market is anticipated to expand at a CAGR of 11.1% during the period from 2013 to 2019
to reach a value of US$8.7 billion by the end of the forecast period.The market study, titled “Molecular
Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 –
2019”, states that the rising geriatric population and the increasing prevalence of chronic diseases
around the world is driving the growth of the molecular diagnostics market all over the world.The
study determines that the next generation sequencing market is emerging as the fastest growing
technological segment of the global molecular diagnostics industry, reporting rapid growth. The brisk
turnaround time of the next generation sequencing technique has helped it gain momentum. The cost
reduction of sequencing has also added to the growth of this market segment. In addition to this, the
PCR market segment, which had dominated the global molecular diagnostics market in 2012, is
projected to lose ground on account of the regular advancement in high yield sequencing technologies.
Request a Sample:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1185
The breakthrough in the molecular cytogenetics technologies such FISH and aCGH are providing new
dimensions to the areas of research and molecular diagnostics. These techniques are considered as
invaluable tool for gene mapping, gene discovery and complex disease trait analysis. Molecular
cytogenetics facilitates diagnosis and prognosis of diseases associated with hematological
malignancies and solid tumors at molecular level. Likewise, alongwith diagnosis and prognosis of
tumors, the technique is facilitating the practice of personalized medicines. The global molecular
cytogenetics market was valued at USD 469.2 million in 2012 and is expected to grow at a CAGR of
23.4% from 2013 to 2019 to reach at an estimated value of USD 1.9 billion in 2019.
Browse Report: http://www.transparencymarketresearch.com/molecular-diagnostics-market.html
aCGH technique is rapidly growing with a CAGR of more than 20% and is poised to lead the market
in the future. aCGH technique is a high resolution tool and its uniqueness lies in performing thousands
of experiments in one array. aCGH has facilitated clinicians to move from sequential diagnostics to
parallel diagnostics which provides accurate analysis at one time. aCGH technique is gradually
evolving and is expected to surpass FISH technique in the coming years owing to its accuracy and
rapid results. aCGH in the next few years would become the primary screening tool while FISH is
expected to become more of a validation tool. Moreover, the technology is highly being preferred over
FISH owing to its ability to detect several genomes simultaneously. As aCGH provides high resolution
copy number variations the technology has numerous application areas in medicine.
Key players in the molecular cytogenetics market include Abbott Laboratories, Applied Spectral
Imaging, Affymetrix, Inc., Agilent Technologies, Inc., Illumina, Inc., Life Technologies Corporation,
among others.
About
Us:
Transparency Market Research (TMR) is a next-generation provider of syndicated research,
customized research, and consulting services. TMR’s global and regional market intelligence coverage
includes industries such as pharmaceutical, chemicals and materials, technology and media, food and
beverages, and consumer goods, among others. Each TMR research report provides clients with a 360degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key
trends, and strategic recommendations.
Contact Us:
Mr.Sudip S.
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

The molecular cytogenetics market has grown from $469.2 million in 2012 to an estimated $1.9 billion in 2019 due to the success of techniques such as fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH). The research report scrutinizes the global market and provides a quantitative and qualitative analysis on the various segments.